Figure 6From: Immunomodulation in stable renal transplant recipients with concomitant tacrolimus and sirolimus therapyCirculating levels of proinflammatory cytokines: Significantly decreased levels of IFN-γ (p < 0.04), IL-4 (p < 0.02) and IL-2 (p < 0.03) in patients treated with TAC and SRL compared to TAC/MMF/Aza are shown.Back to article page